1. Introduction
1.1. Executive Summary
1.2. Market Definition
1.3. The scope of the Study
2. Research Methodology
2.1. Secondary Research
2.2. Primary Research
2.3. Analytics Tools & Model
2.4. Economic Indicators
2.4.1.Base Year, Base Currency & Forecasting Period
2.5. Expert Validation
2.6. Study Timeline
3. Market Analysis
3.1. Industry Value Chain Analysis
3.2. Porter's Five Force Analysis
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of Substitutes
3.2.4 Threat of New Entrants
3.2.5 Industry Rivalry (Competitive Environment)
3.3. PESTLE Analysis
3.3.1 Political
3.3.2 Economical
3.3.3 Social
3.3.4 Technological
3.3.5 Legal
3.3.6 Environmental
3.4. SWOT Analysis
3.4.1 Strengths
3.4.2 Weakness
3.4.3 Opportunities
3.4.4 Threats
3.4.5 Y-O-Y Analysis
4. Market Dynamics
4.1. Drivers
4.1.1 Increase in corporate partnerships to accelerate development and commercialise of regenerative medicine.
4.1.2 Increase in global healthcare expenditure.
4.1.3 Rapid growth in ageing population.
4.1.4. Prevalence of chronic diseases and genetic disorders.
4.2. Restraints
4.2.1 Cost of treatment.
4.2.2 Complex regeneration process.
4.2.3. Lack of guidelines.
4.2.4. Ethical concerns with the use of embryonic stem cell for research and development.
4.3. Opportunities
4.3.1. Strong product pipeline.
4.3.2. The great demand for organ transplantation.
4.4. Challenges
4.4.1 Stringent regulatory policies about stem cell technologies.
5. Americas Regenerative Medicine Market – By Product
5.1 Introduction
5.2 Cell-based products
5.2.1 Allogeneic products
5.2.2 Autologous products
5.3 Acellular products
6. Americas Regenerative Medicine Market - By Application
6.1 Introduction
6.2 Orthopaedic and musculoskeletal disorders
6.3 Dermatology
6.4 Cardiology
6.5 Central nervous system diseases
6.6 Oncology
6.7 Diabetes
6.8 Bone graft substitutes
6.9 Others
7. Americas Regenerative Medicine Market – By Therapy
7.1 Introduction
7.2 Cell therapy
7.3 Immunotherapy
7.4 Tissue therapy
7.5 Gene therapy
7.6 Others
8. Americas Regenerative Medicine Market – By Material
8.1 Introduction
8.2 Algae-derived alginate
8.3 Synthetic polymer
8.4 Poly-lactide-coglycolide
8.5 Poly-ethylene glycol
8.6 Hydrogels
8.7 Others
9. Americas Regenerative Medicine Market – by Agent type
9.1 Introduction
9.2 Biologics
9.2.1 Autologous fibroblasts
9.2.2 Hematopoietic stem and progenitor cells
9.3 Cell-based medical devices
9.3.1 Allogenic fibroblasts
9.3.2 Cell extraction
9.4 Biopharmaceuticals
9.4.1 Tricalcium phosphate
9.4.2 Osteogenic protein
10. Americas Regenerative Medicine Market – By Geography
10.1 Americas
10.1.1 U.S.
10.1.2 Canada
10.1.3 Mexico
10.1.4 Brazil
10.1.5 Argentina
10.1.6. Others
11. Americas Regenerative Medicine Market - Company Profiles
11.1 Celgene Corporation
11.2 Vertex pharmaceuticals
11.3 Acelity L.P. Inc
11.4 Stem cells, Inc.
11.5 Organogenesis Inc
11.6 Nuvasive Inc
11.7 Mesoblast Ltd
11.8 Advantagene Inc
11.9 Vertical corporation
11.10 Cytori therapeutics
12. Americas Regenerative Medicine Market - Competitive Landscape
12.1 Market Share Analysis
12.2 Strategies Adopted by top companies
12.3 Merges, Acquisitions, Collaborations & Agreements
13. Market Insights
13.1 Industry Experts Insights
13.2 Analysts Opinions
13.3 Investment Opportunities
14. Appendix
14.1 List of tables
14.2 List of figures
